SEMINAR AGENDA AND PARTICIPANTS
1) Joint Seminar on “Src and Leuk Genes”
National Institutes of Health, Bethesda, MD, November 12-14, 1979
AGENDA
| November 12, 1979 | ||
| Structure of Endogenous src Protein of CEF | Dr. K. Beemon | |
| Studies on the src Proteins of Recovered Avian Sarcoma Viruses | Dr. J. Neil | |
| The Nature of Genetic Interaction which Generates Recombinant Sarcoma Virus in Chickens | Dr. H. Hanafusa | |
| Unusual Features in the Nucleotide Sequence of a cDNA Clone Derived from the Common Region of Avian Sarcoma Virus Messenger RNA | Dr. T. Yamamoto | |
| A New Mutant Derived from ts-NY68 | Dr. S. Kawai | |
| Protein Phosphorylation Mediated by the Avian Sarcoma Virus Transforming Gene Product | Dr. R. Erikson | |
| Characterization of p60 src Dependent Phosphorylation Products in Cell Free Extracts | Dr. G. Jay | |
| Phosphorylation | Dr. K. Beemon | |
| The Abelson Murine Leukemia Virus Protein is Phosphorylated in vitro to Form Phosphotyrosite | Dr. A. Dasgupta | |
| Protein Phosphorylation in Viral Transformed Cells | Dr. Kin-ichiro Oda | |
| Viral-Chemical Carcinogenesis | Dr. H. Yoshikura | |
| November 13, 1979 | ||
| The src Proteins of Rat-Derived Murine Sarcoma Viruses | Dr. T. Shih | |
| Presence of Linear ds-DNA in KiSV Producers and Its Mapping | Dr. N. Tsuchida | |
| Altered Cytoskeleton in Leukemia Cells | Dr. I. Yahara | |
| Ultrastructural Localization of src Proteins | Dr. M. Willingham | |
| Identification of SFFV-specific Sequences coding for SFFV-specific Glycoprotein, gp-55 | Dr. M. Yoshida | |
| The RNAs of the Detective and Non-Defective Component of Friend Anemia and Polycythemia Virus Identified and Compared: Prototypes of a New Class of Retroviral Transforming Genes | Dr. L. Evans | |
| Further Characterization of SFFV-specific gp-55 | Dr. Y. Ikawa | |
| Some Properties of a Newly Isolated Avian Sarcoma Virus (Y-73) | Dr. K. Toyoshima | |
| Leukemia Specific Sequences in Avian Erythroblastosis Virus | Dr. M. Lai | |
| November 14, 1979 | ||
| The Current Status of Mink Cell Focus Forming Virus | Dr. W. Rowe | |
| Malignant Lymphomas Induced by Avian Leukosis Viruses | Dr. P. Neiman | |
PARTICIPANTS
United States
Dr. Paul Neiman
Division of Oncology
University of Washington School of Medicine
Seattle, Washington 98195
Dr. Ira Pastan
Chief, Laboratory of Molecular Biology
National Cancer Institute
National Institutes of Health
Bethesda, Maryland 20205
Dr. Wallace Rowe
Laboratory of Viral Diseases
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Bethesda, Maryland 20205
Dr. Thomas Shih
Laboratory of Tumor Virus Genetics
National Cancer Institute
National Institutes of Health
Bethesda, Maryland 20205
Dr. Mark C. Willingham
Laboratory of Molecular Biology
National Cancer Institute
National Institutes of Health
Bethesda, Maryland 20205
Dr. Tadashi Yamamoto
Laboratory of Molecular Biology
National Cancer Institute
National Institutes of Health
Bethesda, Maryland 20205
Dr. Jim Neil
Department of Microbiology
University of Southern California School of Medicine
2011 Zonal Avenue
Los Angeles, California 90033
Dr. Karen Beemon
Department of Tumor Virology
The Salk Institute
San Diego, California 92112
Dr. Asim Dasgupta
MIT
Center for Cancer Research
77 Massachusetts Avenue
Cambridge, Massachusetts 02139
Dr. Ray Erikson
University of Colorado Medical
School Department of Pathology
Denver, Colorado 80262
Dr. Leonard Evans
University of California
Department of Molecular Biology
Berkeley, California 94720
Dr. Hidesaburo Hanafusa
The Rockefeller University
New York, New York 10021
Dr. Gilbert Jay
Laboratory of Molecular Virology
National Cancer Institute
National Institutes of Health
Bethesda, Maryland 20205
Dr. Michael Lai
Department of Microbiology
University of Southern California School of Medicine
2011 Zonal Avenue
Los Angeles, California 90033
Japan
Dr. Yoji Ikawa, Chief
Department of Viral Oncology
Cancer Institute
Kami-Ikebukuro, Toshima-ku Tokyo 170, Japan
Dr. Sadaaki Kawai
Associate Professor
Department of Oncostatics
Institute of Medical Science
University of Tokyo
Shiba-Shiroganedai, Minato-ku
Tokyo 108, Japan
Dr. Kin-ichiro Oda
Associate Professor
Department of Cancer Virus
Institute of Medical Science
University of Tokyo
Shiba-Shiroganedai, Minato-ku
Tokyo 108, Japan
Dr. Kumao Toyoshima, Professor
Department of Viral Oncology
Institute of Microbial Diseases
Osaka University
Yamada-ue, Suita-shi
Osaka 565, Japan
Dr. Nobuo Tsuchida
Wistar Institute
36th Street and Spruce
Philadelphia, Pennsylvania 19104
Dr. Ichiro Yahara, Head
Cell Cycle Section
Tokyo Metropolitan Institute of Medical Science
Honkomagome, Bunkyo-ku
Tokyo 113, Japan
Dr. Mitsuaki Yoshida
Chief Associate
Department of Viral Oncology
Cancer Institute
Kami-Ikebukuro, Toshima-ku
Tokyo 170, Japan
Dr. Hiroshi Yoshikura
Associate Professor
Department of Genetics
Institute of Medical Science
University of Tokyo
Shiba-Shiroganedai, Minato-ku
Tokyo 108, Japan
2) Joint Seminar on “Mechanisms of Host Tumor Immunity and Theoretical Basis for Tumor Immunotherapy”
Lahaina Room at the Sheraton-Maui Hotel, October 8-10, 1979
AGENDA
| Monday, October 8 (1) ANTIGENIC NATURE OF TUMOR CELLS Characterization of tumor-associated antigens |
||
| 8:30-9:10 | “Serologic analysis of human osteosarcoma antigens” | Dr. S. Rosenberg (National Cancer Institute) |
| 9:10-9:50 | “Antigen-characteristics of rat bladder cancer and its relevance to immunosensitivity in immunotherapy” | Dr. Y. Hashimoto (Tohoku Univ. Sch. of Pharmacology) |
| 9:50-10:15 | “Definition of immune cell surface antigen associated with leukemia” | Dr. D. Meruelo (New York University Medical Center) |
| (2) FUNDAMENTAL IMMUNOLOGIC PROCESS IN HOST RESPONSES TO TUMORS (a) Mechanisms of macrophage activation and anti-tumor effects |
||
| 10:30-10:15 | “Mode of activation of cytotoxic macrophages” | Dr. T. Tokunaga, (National Institute of Health) |
| 11:15-12:00 | “Correlation between H2O2 release and the ability of macrophages to kill intracellular protozoa and extracellular tumor cells” | Dr. C. Nathan (Rockefeller University) |
| (b) Natural killer cell activity and relevance to tumor-resistance | ||
| 20:00-20:45 | “Surface marker of mouse natural killer cell” | Dr. K. Okumura (Tokyo Univ. Med. Sch.) |
| 20:45-21:30 | “Regulation of natural killer cell activity an evidence for role in vivo” | Dr. R. Herberman (National Cancer Institute) |
| Tuesday, October 9 (c) Regulation of host immune response |
||
| 8:30-9:15 | “Regulation of immunity to UV-radiation-induced skin cancer” | Dr. M. Kripke (Frederick Cancer Research Center) |
| 9:15-10:00 | “Two effector mechanisms against syngeneic tumor in the mouse” | Dr. S. Fujimoto (Chiba Univ. Med. Sch.) |
| 10:30-11:15 | “The cellular basis of the regulation of the immune response to tumor antigen” | Dr. M. Greene (Harvard Medical School) |
| 11:15-12:00 | “H-2D linked mechanism of resistance to radiation leukemia virus” | Dr. D. Meruelo (New York University Medical Center) |
| (3) NEW APPROACHES AND PRECLINICAL TRIALS IN TUMOR IMMUNOTHERAPY | ||
| 20:00-20:45 | “Lectin-bound murine tumor cell vaccine: Its immunogeneic and immunotherapeutic potency enhanced by immunomodulators” | Dr. T. Kataoka (Japanese Foundation for Cancer Research) |
| 20:45-21:30 | “Antitumor activity of quinonyl-N-acetyl-muramyldipeptide derivations” | Dr. I. Azuma (Hokkaido Univ. Res. Inst. for Immunol.) |
| Wednesday, October 10 | ||
| 8:30-9:15 | “The prolonged growth of cytotoxic T lymphoid cells” | Dr. S. Rosenberg (National Cancer Institute) |
| 9:15-10:00 | “Application of T-T cell interaction to tumor immunotherapy” | Dr. T. Hamaoka (Osaka Univ. Med. Sch.) |
| 10:00 – 10:45 | “The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes” | Dr. H. Fujiwara (National Cancer Institute) |
| (4) OPEN DISCUSSION | ||
| 11:00-12:30 | “Application of basic tumor immunology studies to the development of new approaches to tumor immunotherapy” | |
| Chairman-Dr. W. Terry (National Cancer Institute) Japanese Program Leader-Dr. T. Hamaoka (Osaka University) American Program Leader-Dr. R. Hodes (National Cancer Institute) |
||
| Sunday, January 27, 1980 | ||
| Welcoming Address and Introductions | Dr. M. Melamed Dr. Y. Tenjin | |
| An Objective Measure of “How Good” is Cytology Automation | Dr. L. Kamensky | |
| Comparison of Data Analysis in Flow and Imaging Systems | Dr. T. Sharpless | |
| Multidimensional Slit-Scan Flow System and Correlation Studies | Dr. L. Wheeless | |
| An Automatic Detection System of Cancer Cells Based on Multispectral Images | Dr. Y. Noguchi | |
| Comparing Human and Machine Performance | Dr. J. Prewitt | |
| Monoclonal Antibodies from Human Hybridomas as Specific Immunocytochemical Cell Markers | Dr. G. Goldstein | |
| Monday, January 28 | ||
| Specimen Preparation for Automated Cervical Cancer Cytology | Dr. Y. Uei | |
| Improvement of the Preparation Method of Vaginal Smears for Automated Cytology | Dr. Y. Kishigami | |
| Detection of Uterine Cancer with an Automated Slide Preparation Technique and High Resolution Scanning in 3 Colors Using the Three-Gun Saticon Camera | Dr. G. Wied | |
| Automated Cytological Screening System, Cybest Model 3 and Automated Cell Dispersion and Smearing System | Dr. N. Tanaka | |
| Cost and Performance of Cervical Cancer Prescreening Systems | Dr. K. Castleman | |
| Cytoanalysis by a new system using an Image Sensor | Dr. M. Takahashi | |
| A Study on the Evaluation of the Possibility of Using Flow Cytometry in the First Screening by Automated Cytology | Dr. Y. Tenjin | |
| Regulation of the Cell Cycle by Steroid Hormones in HELA Cells: Flow Cytometric Analysis | Dr. I. Nishiya | |
| Recognition of Adenocarcinoma in Automated Uterine Cytology | Dr. M. Onoe | |
| Flow Cytometry Diagnosis of Carcinoma of the Urinary Bladder | Dr. M. Melamed | |
| Tuesday, January 29 | ||
| Use of Cytometry for Classification of Leukocytes and Leukemias with the Technicon Hemalog D | Dr. L. Ornstein | |
| Leukemia Classification and Treatment Monitoring by Flow Cytometry | Dr. M. Andreeff | |
| An Overview of the Los Alamos Scientific Laboratory Program in Flow Cytometry | Dr. P. Mullaney | |
| An Overview of the Analytic Cytology Program in the Biomedical Sciences Division of the Lawrence Livermore Laboratories | Dr. M. Mendelsohn | |